Sequences

Sample result

Human insulin's gene

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

1,584 publications in 1,066 families match these filters.

  1. Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof

    Celera Corporation (US)

    Query Match 6.6%Identity 92.6%Family of 10

    Best alignment and family

    Query 183 to 209, hit 7933 to 7907. Positions start at 1 and include both ends.

    Query  183 GCAGGTGGGGCAGGTGGAGCTGGGCGG 209
               |||| |||||||| |||||||||||||
    Hit   7933 GCAGCTGGGGCAGCTGGAGCTGGGCGG 7907
    

    25 of 27 identical, no gaps.

    Family of 10

    Grouped by a shared priority claim, US 60/524882.

  2. No title on record

    Galapagos Genomics N.V. (BE)

    Query Match 6.6%Identity 81.8%

    Best alignment

    Query 14 to 56, hit 121 to 164. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit   121 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 164
    

    36 of 44 identical, 1 gap.

  3. Breast cancer prognostics

    Veridex, LLC (US)

    Query Match 6.6%Identity 83.3%Family of 2

    Best alignment and family

    Query 14 to 56, hit 98 to 141. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit    98 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 141
    

    36 of 44 identical, 1 gap.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  4. EP 1572962-A22005-09-14

    BIOINFORMATICALLY DETECTABLE GROUP OF NOVEL REGULATORY GENES AND USES THEREOF

    ROSETTA GENOMICS LTD

    Query Match 6.6%Identity 100.0%

    Best alignment

    Query 1 to 22, hit 11 to 32. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCC 22
             ||||||||||||||||||||||
    Hit   11 ATGGCCCTGTGGATGCGCCTCC 32
    

    22 of 22 identical, no gaps.

  5. JP 2006519591-A2006-08-31

    Diagnosis and Prognosis of Breast Cancer Patients

    Rosetta Inpharmatics LLC JUERGEN HERMANN NETT

    Query Match 6.6%Identity 92.6%

    Best alignment

    Query 183 to 209, hit 586 to 560. Positions start at 1 and include both ends.

    Query 183 GCAGGTGGGGCAGGTGGAGCTGGGCGG 209
              |||| |||||||| |||||||||||||
    Hit   586 GCAGCTGGGGCAGCTGGAGCTGGGCGG 560
    

    25 of 27 identical, no gaps.

  6. Glomerular expression profiling

    Tryggvason, Karl (SE)

    Query Match 6.6%Identity 81.8%

    Best alignment

    Query 14 to 56, hit 83 to 126. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit    83 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 126
    

    36 of 44 identical, 1 gap.

  7. JP 2006525994-A2006-11-16

    Methods of Inducing Regulated Pancreatic Hormone Production in Non-Pancreatic Islet Tissues

    Sarah FERBER

    Query Match 6.6%Identity 100.0%Family of 2

    Best alignment and family

    Query 279 to 300, hit 22 to 1. Positions start at 1 and include both ends.

    Query 279 ACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||
    Hit    22 ACAATGCTGTACCAGCATCTGC 1
    

    22 of 22 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, US 60/469715.

  8. US 7171311-A2007-01-30

    Methods of assigning treatment to breast cancer patients

    Rosetta Inpharmatics LLC and Netherlands Cancer Institute

    Query Match 6.6%Identity 92.6%

    Best alignment

    Query 183 to 209, hit 586 to 560. Positions start at 1 and include both ends.

    Query 183 GCAGGTGGGGCAGGTGGAGCTGGGCGG 209
              |||| |||||||| |||||||||||||
    Hit   586 GCAGCTGGGGCAGCTGGAGCTGGGCGG 560
    

    25 of 27 identical, no gaps.

  9. EP 1754795-A12007-02-21

    Predicting bone relapse of breast cancer

    Veridex, LLC (US)

    Query Match 6.6%Identity 81.8%

    Best alignment

    Query 14 to 56, hit 98 to 141. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit    98 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 141
    

    36 of 44 identical, 1 gap.

  10. JP 2007507204-A2007-03-29

    BIOMARKERS OF CYCLIN-DEPENDENT KINASE MODULATION

    Bristol-Myers Squibb Company

    Query Match 6.6%Identity 92.6%

    Best alignment

    Query 183 to 209, hit 586 to 560. Positions start at 1 and include both ends.

    Query 183 GCAGGTGGGGCAGGTGGAGCTGGGCGG 209
              |||| |||||||| |||||||||||||
    Hit   586 GCAGCTGGGGCAGCTGGAGCTGGGCGG 560
    

    25 of 27 identical, no gaps.

  11. EP 1782315-A22007-05-09

    Prognosis of breast cancer patients

    ROSETTA INPHARMATICS LLC

    Query Match 6.6%Identity 81.8%

    Best alignment

    Query 14 to 56, hit 121 to 164. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit   121 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 164
    

    36 of 44 identical, 1 gap.

  12. Conditionally-immortalised pancreatic cells

    Reneuron Limited (GB)

    Query Match 6.6%Identity 100.0%Family of 2

    Best alignment and family

    Query 138 to 159, hit 1 to 22. Positions start at 1 and include both ends.

    Query 138 AGGCTTCTTCTACACACCCAAG 159
              ||||||||||||||||||||||
    Hit     1 AGGCTTCTTCTACACACCCAAG 22
    

    22 of 22 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  13. EP 1809762-A12007-07-25

    Methods, systems, and arrays based on correlating p53 status with gene expression profiles, for classification, prognosis, and diagnosis of cancers

    AGENCY SCIENCE TECH & RES

    Query Match 6.6%Identity 81.8%

    Best alignment

    Query 14 to 56, hit 98 to 141. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit    98 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 141
    

    36 of 44 identical, 1 gap.

  14. JP 2007535330-A2007-12-06

    NOVEL THERAPEUTIC TARGETS IN CANCER

    SAGRES DISCOVERY INC,Albert LAI,Ali FATTAEY

    Query Match 6.6%Identity 79.2%

    Best alignment

    Query 254 to 298, hit 19670 to 19623. Positions start at 1 and include both ends.

    Query   254 CCCTGCAGAAGCGTGGCATTGTGGAACAA---TGCTGTACCAGCATCT 298
                ||||||||||||  ||||| |||| ||||   ||| || |||||| ||
    Hit   19670 CCCTGCAGAAGCCAGGCATGGTGGCACAAGCCTGCAGTCCCAGCAACT 19623
    

    38 of 48 identical, 3 gaps.

  15. US 7314974-A2008-01-01

    Expression of microbial proteins in plants for production of plants with improved properties

    Monsanto Technology, LLC

    Query Match 6.6%Identity 92.6%

    Best alignment

    Query 197 to 223, hit 1286 to 1312. Positions start at 1 and include both ends.

    Query  197 TGGAGCTGGGCGGGGGCCCTGGTGCAG 223
               |||||||||||||| ||| ||||||||
    Hit   1286 TGGAGCTGGGCGGGCGCCATGGTGCAG 1312
    

    25 of 27 identical, no gaps.

  16. US 7332281-A2008-02-19

    Therapeutic targets in cancer

    Sagres Discovery, Inc.

    Query Match 6.6%Identity 79.2%

    Best alignment

    Query 254 to 298, hit 19670 to 19623. Positions start at 1 and include both ends.

    Query   254 CCCTGCAGAAGCGTGGCATTGTGGAACAA---TGCTGTACCAGCATCT 298
                ||||||||||||  ||||| |||| ||||   ||| || |||||| ||
    Hit   19670 CCCTGCAGAAGCCAGGCATGGTGGCACAAGCCTGCAGTCCCAGCAACT 19623
    

    38 of 48 identical, 3 gaps.

  17. JP 2008504803-A2008-02-21

    CELL-TYPE-SPECIFIC PATTERNS OF GENE EXPRESSION

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SIDNEY KIMMEL CANCER CENTER

    Query Match 6.6%Identity 82.9%Family of 2

    Best alignment and family

    Query 14 to 56, hit 121 to 164. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit   121 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 164
    

    36 of 44 identical, 1 gap.

    Family of 2

    Grouped by a shared priority claim, US 60/535382.

  18. JP 2008517608-A2008-05-29

    Ungulates with Genetically Modified Immune Systems

    Revivicor Inc

    Query Match 6.6%Identity 81.4%Family of 6

    Best alignment and family

    Query 170 to 209, hit 26326 to 26284. Positions start at 1 and include both ends.

    Query   170 AGGCAGAGGACCTGCAGGTGGGGCAGG---TGGAGCTGGGCGG 209
                ||| ||||  |||||||||||||||||    ||| ||||||||
    Hit   26326 AGGTAGAGCTCCTGCAGGTGGGGCAGGCTCAGGAACTGGGCGG 26284
    

    35 of 43 identical, 3 gaps.

    Family of 6

    Grouped by a shared priority claim, US 60/621433.

  19. JP 2008521383-A2008-06-26

    METHODS, SYSTEMS, AND ARRAYS BASED ON CORRELATING P53 STATUS WITH GENE EXPRESSION PROFILES, FOR CLASSIFICATION, PROGNOSIS, AND DIAGNOSIS OF CANCERS

    AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH

    Query Match 6.6%Identity 81.8%

    Best alignment

    Query 14 to 56, hit 98 to 141. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit    98 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 141
    

    36 of 44 identical, 1 gap.

  20. US 7482117-A2009-01-27

    Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof

    Celera Corporation

    Query Match 6.6%Identity 92.6%Family of 12

    Best alignment and family

    Query 183 to 209, hit 7933 to 7907. Positions start at 1 and include both ends.

    Query  183 GCAGGTGGGGCAGGTGGAGCTGGGCGG 209
               |||| |||||||| |||||||||||||
    Hit   7933 GCAGCTGGGGCAGCTGGAGCTGGGCGG 7907
    

    25 of 27 identical, no gaps.

    Family of 12

    Grouped by a shared priority claim, US 60/504955.

  21. US 7514209-A2009-04-07

    Diagnosis and prognosis of breast cancer patients

    Rosetta Inpharmatics LLC and The Netherlands Cancer Institute

    Query Match 6.6%Identity 92.6%

    Best alignment

    Query 183 to 209, hit 586 to 560. Positions start at 1 and include both ends.

    Query 183 GCAGGTGGGGCAGGTGGAGCTGGGCGG 209
              |||| |||||||| |||||||||||||
    Hit   586 GCAGCTGGGGCAGCTGGAGCTGGGCGG 560
    

    25 of 27 identical, no gaps.

  22. JP 2009536035-A2009-10-08

    PANCREATIC ISLET-LIKE CELLS

    OPEXA THERAPEUTICS

    Query Match 6.6%Identity 100.0%

    Best alignment

    Query 134 to 155, hit 1 to 22. Positions start at 1 and include both ends.

    Query 134 AACGAGGCTTCTTCTACACACC 155
              ||||||||||||||||||||||
    Hit     1 AACGAGGCTTCTTCTACACACC 22
    

    22 of 22 identical, no gaps.

  23. US 7618814-A2009-11-17

    Microrna-related nucleic acids and uses thereof

    Rosetta Genomics Ltd.

    Query Match 6.6%Identity 100.0%

    Best alignment

    Query 1 to 22, hit 11 to 32. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCC 22
             ||||||||||||||||||||||
    Hit   11 ATGGCCCTGTGGATGCGCCTCC 32
    

    22 of 22 identical, no gaps.

  24. US 7638288-B22009-12-29

    Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts

    Galapagos N.V.

    Query Match 6.6%Identity 81.8%Family of 2

    Best alignment and family

    Query 14 to 56, hit 121 to 164. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit   121 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 164
    

    36 of 44 identical, 1 gap.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  25. EP 2186913-A22010-05-19

    Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof

    Bristol-Myers Squibb Company (US)

    Query Match 6.6%Identity 92.6%

    Best alignment

    Query 183 to 209, hit 7933 to 7907. Positions start at 1 and include both ends.

    Query  183 GCAGGTGGGGCAGGTGGAGCTGGGCGG 209
               |||| |||||||| |||||||||||||
    Hit   7933 GCAGCTGGGGCAGCTGGAGCTGGGCGG 7907
    

    25 of 27 identical, no gaps.

  26. Temperature sensitive mutants of matrix metalloprotease 1 und uses thereof

    HALOZYME INC

    Query Match 6.6%Identity 81.8%

    Best alignment

    Query 14 to 56, hit 121 to 164. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit   121 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 164
    

    36 of 44 identical, 1 gap.

  27. US 7863001-B22011-01-04

    Diagnosis and prognosis of breast cancer patients

    The Netherlands Cancer Institute and Merck Sharp & Dohme Corp.

    Query Match 6.6%Identity 92.6%Family of 2

    Best alignment and family

    Query 183 to 209, hit 586 to 560. Positions start at 1 and include both ends.

    Query 183 GCAGGTGGGGCAGGTGGAGCTGGGCGG 209
              |||| |||||||| |||||||||||||
    Hit   586 GCAGCTGGGGCAGCTGGAGCTGGGCGG 560
    

    25 of 27 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  28. NOVEL TUMOR MARKERS

    KONINKL PHILIPS ELECTRONICS NV

    Query Match 6.6%Identity 92.3%

    Best alignment

    Query 14 to 56, hit 83 to 126. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit    83 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 126
    

    36 of 44 identical, 1 gap.

  29. NOVEL TUMOR MARKERS

    KONINKL PHILIPS ELECTRONICS NV

    Query Match 6.6%Identity 92.3%

    Best alignment

    Query 14 to 56, hit 83 to 126. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit    83 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 126
    

    36 of 44 identical, 1 gap.

  30. NOVEL TUMOR MARKERS

    KONINKL PHILIPS ELECTRONICS NV

    Query Match 6.6%Identity 92.3%

    Best alignment

    Query 14 to 56, hit 83 to 126. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit    83 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 126
    

    36 of 44 identical, 1 gap.

  31. NOVEL TUMOR MARKERS SELECTED FROM A GROUP OF cAMP-REGULATORY PATHWAY MEMBERS

    KONINKL PHILIPS ELECTRONICS NV

    Query Match 6.6%Identity 81.8%

    Best alignment

    Query 14 to 56, hit 83 to 126. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit    83 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 126
    

    36 of 44 identical, 1 gap.

  32. JP 2011517318-A2011-06-02

    In Vivo Temporal Control of Activatable Matrix-Degrading Enzymes

    Halozyme Inc

    Query Match 6.6%Identity 81.8%Family of 4

    Best alignment and family

    Query 14 to 56, hit 121 to 164. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit   121 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 164
    

    36 of 44 identical, 1 gap.

    Family of 4

    Grouped by a shared priority claim, US 61/068667.

  33. US 8014957-B22011-09-06

    Genes associated with progression and response in chronic myeloid leukemia and uses thereof

    Fred Hutchinson Cancer Research Center and Rosetta Inpharmatics LLC

    Query Match 6.6%Identity 92.6%

    Best alignment

    Query 183 to 209, hit 586 to 560. Positions start at 1 and include both ends.

    Query 183 GCAGGTGGGGCAGGTGGAGCTGGGCGG 209
              |||| |||||||| |||||||||||||
    Hit   586 GCAGCTGGGGCAGCTGGAGCTGGGCGG 560
    

    25 of 27 identical, no gaps.

  34. US 8065093-B22011-11-22

    Methods, systems, and compositions for classification, prognosis, and diagnosis of cancers

    Agency For Science, Technology, And Research

    Query Match 6.6%Identity 81.8%Family of 2

    Best alignment and family

    Query 14 to 56, hit 98 to 141. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit    98 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 141
    

    36 of 44 identical, 1 gap.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  35. US 8119405-B22012-02-21

    Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues

    Query Match 6.6%Identity 100.0%

    Best alignment

    Query 279 to 300, hit 22 to 1. Positions start at 1 and include both ends.

    Query 279 ACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||
    Hit    22 ACAATGCTGTACCAGCATCTGC 1
    

    22 of 22 identical, no gaps.

  36. EP 2435360-A22012-04-04

    NANODIAMOND PARTICLE COMPLEXES

    NORTH WESTERN UNIVERSITY

    Query Match 6.6%Identity 100.0%

    Best alignment

    Query 311 to 332, hit 26 to 5. Positions start at 1 and include both ends.

    Query 311 AGCTGGAGAACTACTGCAACTA 332
              ||||||||||||||||||||||
    Hit    26 AGCTGGAGAACTACTGCAACTA 5
    

    22 of 22 identical, no gaps.

  37. JP 2012519494-A2012-08-30

    TEMPERATURE SENSITIVE MUTANTS OF MATRIX METALLOPROTEASES AND USES THEREOF

    Halozyme Inc

    Query Match 6.6%Identity 81.8%Family of 2

    Best alignment and family

    Query 14 to 56, hit 121 to 164. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit   121 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 164
    

    36 of 44 identical, 1 gap.

    Family of 2

    Grouped by a shared priority claim, US 61/209366.

  38. METHOD FOR IDENTIFYING A SUBSET OF POLYNUCLEOTIDES FROM AN INITIAL SET OF POLYNUCLEOTIDES CORRESPONDING TO THE HUMAN GENOME FOR THE IN VITRO DETERMINATION OF THE SEVERITY OF THE HOST RESPONSE OF A PATIENT

    SIRS LAB GMBH

    Query Match 6.6%Identity 81.8%Family of 2

    Best alignment and family

    Query 14 to 56, hit 121 to 164. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit   121 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 164
    

    36 of 44 identical, 1 gap.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  39. JP 2012528197-A2012-11-12

    Nanodiamond Particle Complexes

    Northwestern University

    Query Match 6.6%Identity 100.0%Family of 2

    Best alignment and family

    Query 311 to 332, hit 26 to 5. Positions start at 1 and include both ends.

    Query 311 AGCTGGAGAACTACTGCAACTA 332
              ||||||||||||||||||||||
    Hit    26 AGCTGGAGAACTACTGCAACTA 5
    

    22 of 22 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  40. AN INSULIN ANALOGUE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION WITH PROLONGED THERAPEUTIC EFFECT, USE OF THE INSULIN ANALOGUE, DOSAGE METHOD AND METHOD OF TREATMENT OF DIABETES

    INST BIOTECHNOLOGII I ANTYBIOTYKOW

    Query Match 6.6%Identity 78.7%

    Best alignment

    Query 118 to 164, hit 9203 to 9249. Positions start at 1 and include both ends.

    Query  118 TACCTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCG 164
               ||||| || || || ||||| || ||||||||||| || || || ||
    Hit   9203 TACCTGGTATGTGGCGAACGTGGTTTCTTCTACACTCCTAAAACACG 9249
    

    37 of 47 identical, no gaps.

  41. LONG INTERGENIC NON-CODING RNAS IN MAIZE

    DU PONTa

    Query Match 6.6%Identity 93.5%

    Best alignment

    Query 242 to 271, hit 668 to 697. Positions start at 1 and include both ends.

    Query 242 CCCTGGAGGGGTCCCTGCAGAAGCG-TGGCA 271
              ||||||||||| ||||||||||||| |||||
    Hit   668 CCCTGGAGGGG-CCCTGCAGAAGCGTTGGCA 697
    

    29 of 31 identical, 2 gaps.

  42. US 8906383-B22014-12-09

    T cell receptor having binding affinity for a peptide-MHC complex and uses thereof

    King's College London

    Query Match 6.6%Identity 100.0%

    Best alignment

    Query 312 to 333, hit 30 to 9. Positions start at 1 and include both ends.

    Query 312 GCTGGAGAACTACTGCAACTAG 333
              ||||||||||||||||||||||
    Hit    30 GCTGGAGAACTACTGCAACTAG 9
    

    22 of 22 identical, no gaps.

  43. US 9024113-B22015-05-05

    Polynucleotides for expression of microbial starch branching enzymes in plants for production of plants with improved yield

    Monsanto Technology LLC

    Query Match 6.6%Identity 92.6%

    Best alignment

    Query 197 to 223, hit 1286 to 1312. Positions start at 1 and include both ends.

    Query  197 TGGAGCTGGGCGGGGGCCCTGGTGCAG 223
               |||||||||||||| ||| ||||||||
    Hit   1286 TGGAGCTGGGCGGGCGCCATGGTGCAG 1312
    

    25 of 27 identical, no gaps.

  44. EP 2998396-A12016-03-23

    Manipulation of hairy and enhancer of split 3 (Hes3) and its regulators/mediators in diabetes, obesity, and metabolic syndrome

    TECH UNIVERSITAT DRESDEN

    Query Match 6.6%Identity 100.0%Family of 2

    Best alignment and family

    Query 310 to 331, hit 22 to 1. Positions start at 1 and include both ends.

    Query 310 CAGCTGGAGAACTACTGCAACT 331
              ||||||||||||||||||||||
    Hit    22 CAGCTGGAGAACTACTGCAACT 1
    

    22 of 22 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  45. US 9481894-B22016-11-01

    Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.

    Query Match 6.6%Identity 100.0%

    Best alignment

    Query 279 to 300, hit 22 to 1. Positions start at 1 and include both ends.

    Query 279 ACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||
    Hit    22 ACAATGCTGTACCAGCATCTGC 1
    

    22 of 22 identical, no gaps.

  46. US 9518277-B22016-12-13

    Genetically engineered microbial strains including Chlorella protothecoides lipid pathway genes

    TerraVia Holdings, Inc.

    Query Match 6.6%Identity 89.7%

    Best alignment

    Query 23 to 62, hit 1930 to 1965. Positions start at 1 and include both ends.

    Query   23 TGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGACCC 62
               ||||||||||||  ||||||| |||    |||||||||||
    Hit   1930 TGCCCCTGCTGGGCCTGCTGGGCCT----GGACCTGACCC 1965
    

    33 of 40 identical, 4 gaps.

  47. US 9567581-B22017-02-14

    Selective reactivation of genes on the inactive X chromosome

    The General Hospital Corporation

    Query Match 6.6%Identity 92.6%

    Best alignment

    Query 183 to 209, hit 737 to 711. Positions start at 1 and include both ends.

    Query 183 GCAGGTGGGGCAGGTGGAGCTGGGCGG 209
              |||| |||||||| |||||||||||||
    Hit   737 GCAGCTGGGGCAGCTGGAGCTGGGCGG 711
    

    25 of 27 identical, no gaps.

  48. US 9585942-B22017-03-07

    Insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, use of the insulin analogue, dosage method and method of treatment of diabetes

    Instytut Biotechnologii i Antybiotykow

    Query Match 6.6%Identity 78.7%

    Best alignment

    Query 118 to 164, hit 9203 to 9249. Positions start at 1 and include both ends.

    Query  118 TACCTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCG 164
               ||||| || || || ||||| || ||||||||||| || || || ||
    Hit   9203 TACCTGGTATGTGGCGAACGTGGTTTCTTCTACACTCCTAAAACACG 9249
    

    37 of 47 identical, no gaps.

  49. EP 3160503-A12017-05-03

    INHIBITION OF SEROTONIN EXPRESSION IN GUT ENTEROENDOCRINE CELLS RESULTS IN CONVERSION TO INSULIN-POSITIVE CELLS

    UNIV COLUMBIA

    Query Match 6.6%Identity 100.0%

    Best alignment

    Query 118 to 139, hit 1 to 22. Positions start at 1 and include both ends.

    Query 118 TACCTAGTGTGCGGGGAACGAG 139
              ||||||||||||||||||||||
    Hit     1 TACCTAGTGTGCGGGGAACGAG 22
    

    22 of 22 identical, no gaps.

  50. US 9775889-B22017-10-03

    Methods of treatment of cellulite

    Halozyme, Inc.

    Query Match 6.6%Identity 81.8%

    Best alignment

    Query 14 to 56, hit 121 to 164. Positions start at 1 and include both ends.

    Query  14 TGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCC-TCTGGGGACC 56
              || ||||||| |||  ||||| |||||||||||  |||||| ||
    Hit   121 TGTGCCTCCTCCCCGCGCTGGTGCTGCTGGCCCGGCTGGGGGCC 164
    

    36 of 44 identical, 1 gap.